| Literature DB >> 32208685 |
Stella Cascioferro1, Barbara Parrino1, Daniela Carbone1, Domenico Schillaci1, Elisa Giovannetti2,3, Girolamo Cirrincione1, Patrizia Diana1.
Abstract
Thiazoles, their benzofused systems, and thiazolidinone derivatives are widely recognized as nuclei of great value for obtaining molecules with various biological activities, including analgesic, anti-inflammatory, anti-HIV, antidiabetic, antitumor, and antimicrobial. In particular, in the past decade, many compounds bearing these heterocycles have been studied for their promising antibacterial properties due to their action on different microbial targets. Here we assess the recent development of this class of compounds to address mechanisms underlying antibiotic resistance at both bacterial-cell and community levels (biofilms). We also explore the SAR and the prospective clinical application of thiazole and its benzofused derivatives, which act as inhibitors of mechanisms underlying antibiotic resistance in the treatment of severe drug-resistant infections. In addition, we examined all bacterial targets involved in their antimicrobial activity reporting, when described, their spontaneous frequencies of resistance.Entities:
Year: 2020 PMID: 32208685 DOI: 10.1021/acs.jmedchem.9b01245
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446